Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,778 public trials 699 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma

NCT02920697

Conditions
B-Cell Non-Hodgkin Lymphoma (NHL), Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services Melbourne, Australia
  • Hopital Claude Huriez Lille, France
  • CHU de Nantes Nantes, France
  • Centre hospitalier Lyon Sud Pierre-Bénite, France
View all 18 locations
View Trial Details
Completed

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

NCT02576496

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Cutaneous T Cell Lymphoma, +23 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Cancer Center Jacksonville, Florida, United States
  • Columbia University Medical Center New York, United States
  • University Hospitals Cleveland Seidman Cancer Center Cleveland, Ohio, United States
View all 18 locations
View Trial Details
Completed

Lenalidomide Plus Rituxan for Untreated Mantle Cell Lymphoma

NCT01472562

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Weill Cornell Medical College New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation

NCT03942263

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • State budgetary healthcare institution of the Astrakhan region Alexander-Mariinsky regional clinical hospital Astrakhan, Russia
  • Autonomous Institution "Republican Clinical Oncology Dispensary" of the Ministry of Health of Chuvashia Cheboksary, Russia
  • State budgetary health care institution "Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine" Chelyabinsk, Russia
  • State Budget Public Health Institution "Regional Oncological Dispensary" Irkutsk, Russia
View all 50 locations
View Trial Details
Completed

Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy

NCT02464228

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 13 locations
View Trial Details

Related conditions